Investment Opportunities in the Topical Drug Delivery Market: A Comprehensive Outlook for 2030
The global topical drug delivery market is witnessing significant growth, fueled by the rising prevalence of skin diseases and burn injuries worldwide. According to the World Health Organization (WHO), approximately 180,000 deaths are recorded each year due to burns globally, with burn injuries being a major cause of death. Moreover, burns have a high probability of resulting in disabilities, impacting individuals' lives profoundly. In addition, common skin conditions such as benign tumors, acne, cancers, eczema (atopic dermatitis), contact dermatitis, and psoriasis are a growing concern, especially among the elderly population.
For More Industry Insight Read : https://www.fairfieldmarketresearch.com/report/topical-drugdelivery-market
To mitigate the aftereffects of these skin diseases, the use of non-invasive topical products has gained traction. The American Academy of Dermatology reports that one out of four individuals in the United States suffers from skin diseases, amounting to approximately US$75 billion in medical costs, including prescription and non-prescription drugs. Consequently, the demand for topical drug delivery products, including ointments, lotions, patches, creams, gels, and powders, is expected to increase, driving the growth of the topical drug delivery market.
Inclination Toward Self-Administration of Drugs Spurs Market Growth
The rising inclination toward self-administration of drugs and home care settings is creating new avenues of growth for the topical drug delivery market. The increasing geriatric population is a crucial
factor influencing this trend, as it drives the demand for transdermal, nasal, and other drug delivery systems. Home care settings prove to be effective post-diagnosis for both patients and caregivers. Furthermore, the availability of topical drug delivery products allows targeted treatment without the need for clinical support, leading to a significant reduction in healthcare costs and burden. As a result, home healthcare and self-administration of drugs are expected to drive market growth globally.
Transdermal Products Witness High Demand
The demand for transdermal products is projected to increase significantly in the coming years. Transdermal products offer several perceived advantages, including prolonged drug effect duration, reduced dosing frequency, uniform plasma levels, ease of terminating drug administration, and minimal discomfort or adverse effects for patients. Among transdermal products, patches have gained substantial popularity. Transdermal patches enable effective drug delivery, with easy application, simple treatment regimes, non-invasiveness, and the avoidance of first-pass and peak dose effects.
Transdermal patches provide controlled and prolonged drug delivery, offering convenience and ease of administration as an alternative route of administration. These factors contribute to the growth of the topical drug delivery market.
North America Takes the Lead in the Topical Drug Delivery Market
North America is expected to hold a significant share in the global topical drug delivery market. The region's rise in skin disorders and cases of major and minor skin injuries has contributed to this growth. Acne, one of the most common skin disorders, affects approximately 50 million individuals in the United States, according to the American Academy of Dermatology (AAD). Additionally, 1 in 10 individuals is likely to develop atopic dermatitis, which affects around 25% of children and 2-3% of the adult population. Moreover, GLOBOCAN reported around 105,000 new melanoma skin cancer cases in the region in 2020, with an estimated increase to 142,000 by 2040. Increasing spending on topical derma products, coupled with a stable rise in GDP per capita, is expected to drive the topical drug delivery market's growth in the region.
COVID-19 Impact and Market Developments
The COVID-19 outbreak has had a significant influence on the topical drug delivery market in North America. The outbreak led to the development of novel treatments and products, such as the US FDAapproved T3X ointment by Advanced Penetration Technology, which has shown efficacy against the SARS-CoV-2 virus. Additionally, the region has witnessed rising approvals for new launches by companies, such as the FDA-approved Winlevi cream by Cassiopea SpA for acne treatment. These factors continue to propel the growth of the topical drug delivery market in the region.
Competitive Landscape
In the topical drug delivery market, companies are adopting various growth strategies, including capacity expansions, agreements, acquisitions, collaborations, and new product launches. Some of the major players in the market include Galderma, Novartis International AG, Teva Pharmaceuticals Industries Ltd., Cipla, Pfizer Inc., Rusan Pharma Ltd., Bristol Myers Squibb, and AbbVie Inc.
Web : https://www.fairfieldmarketresearch.com/